Hypotension and Resistance to Lipopolysaccharide-Induced Shock in Transgenic Mice Overexpressing Adrenomedullin in Their Vasculature
Authors:
- Hiroki KuriharaHKHiroki Kurihara
- Koji MaemuraKMKoji Maemura
- Yukiko KuriharaYKYukiko Kurihara
- Tomoyuki KuwakiTKTomoyuki Kuwaki
- Taro IzumidaTITaro Izumida
- Naoto MinaminoNMNaoto Minamino
- Ki-Hwan JuKJKi-Hwan Ju
- Hiroyuki MoritaHMHiroyuki Morita
- Yoshio Oh-HashiYOYoshio Oh-Hashi
- Mamoru KumadaMKMamoru Kumada
- Kenji KangawaKKKenji Kangawa
- 16 May 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (19) , 2309-2316
Abstract
Background—Adrenomedullin (AM) is a vasodilating peptide involved in the regulation of circulatory homeostasis and in the pathophysiology of certain cardiovascular diseases. To determine the extent to which chronic AM overproduction affects circulatory physiology under normal and pathological conditions, we used a preproendothelin-1 promoter to establish transgenic mouse lines overexpressing AM in their vasculature.Methods and Results—Transgenic mice overexpressing AM mainly in vascular endothelial and smooth muscle cells exhibited significantly lower blood pressure (BP) and higher plasma cGMP levels than their wild-type littermates. Blockade of NO synthase withNG-monomethyl-l-arginine elevated BP to a greater degree in AM transgenic mice, offsetting the BP difference between the 2 groups. Despite their lower basal BP, administration of bacterial lipopolysaccharide elicited smaller declines in BP and less severe organ damage in AM transgenic mice than in wild-type mice. Furthermore, the 24-hour survival rate after induction of lipopolysaccharide shock was significantly higher in the transgenic mice.Conclusions—A chronic increase in vascular AM production reduces BP at least in part via an NO-dependent pathway. In addition, smaller responses to LPS in transgenic mice suggest that AM is protective against the circulatory collapse, organ damage, and mortality characteristic of endotoxic shock.Keywords
This publication has 31 references indexed in Scilit:
- Increased plasma adrenomedullin levels in chronic congestive heart failureAmerican Heart Journal, 1996
- Endotoxin Markedly Elevates Plasma Concentration and Gene Transcription of Adrenomedullin in RatBiochemical and Biophysical Research Communications, 1995
- Attenuation of adrenomedullin‐induced renal vasodilatation by NG‐nitro L‐arginine but not glibenclamideBritish Journal of Pharmacology, 1995
- Interleukin-1, Tumor Necrosis Factor and Lipopolysaccharide Additively Stimulate Production of Adrenomedullin in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1995
- Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.Journal of Clinical Investigation, 1994
- Endothelial Cells Actively Synthesize and Secrete AdrenomedullinBiochemical and Biophysical Research Communications, 1994
- Adrenomedullin Stimulates Cyclic AMP Formation in Rat Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasmaFEBS Letters, 1994
- Molecular Cloning and Biological Activities of Rat Adrenomedullin, a Hypotensive PeptideBiochemical and Biophysical Research Communications, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993